✦ LIBER ✦

Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumors

✍ Scribed by Arlene Chan; Shailendra Verma; Sibylle Loibl; Jeffrey Crawford; Mi Rim Choi; Lyndah Dreiling; Ted Vandenberg

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Underreporting of neutropenic toxicity a

✍ Stephanie A. Gregory; Steve Abella; Tim Moore 📂 Article 📅 2011 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 140 KB

Double-conditioning regimens consisting

✍ Hara, J; Osugi, Y; Ohta, H; Matsuda, Y; Nakanishi, K; Takai, K; Fujisaki, H; Tok 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 51 KB

Current Status of Cetuximab for the Trea

✍ Frieze, D. A 📂 Article 📅 2006 🏛 Harvey Whitney Books Company 🌐 English ⚖ 62 KB

Selective regimen shift and demographic

✍ César A.D. Pereira; Élcio S. Leal; Édison L. Durigon 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 638 KB

Rationale for the treatment of solid tum

✍ James C. Cusack 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 303 KB

Allogeneic Hematopoietic Stem Cell Trans

✍ Y. Kamiyama; A. Makimoto; S.-W. Kim; K. Yakushijin; A. Hosono; N. Ueno; S. Fukuh 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB